BACKGROUND AND AIM: The purpose of this study was to describe the computed tomography (CT) findings of @entity2857 -treated @entity99 in @entity1 with @entity157 and to correlate the findings to the overall survival (OS). METHODS: Twenty-eight @entity2857 -treated @entity1 who had @entity157 ( @entity157 ) with viable @entity99 between August 2007 and February 2008 were enrolled in the study. Dynamic CT findings were analyzed with regard to the response of the @entity5 , based on the response evaluation criteria in solid @entity5 , version 1.1, and the attenuation values of the @entity5 during the late arterial and portal venous phases. Survival analyses according to early changes in the @entity5 were also performed. RESULTS: In all @entity1 , the @entity5 responses were stable disease or progressive disease on follow-up CT scans. Prior to the treatment, the mean attenuation values of the @entity5 were 93.0    20.0 Hounsfield unit (HU) at the late arterial phase, and 107.9    23.0 HU at the portal venous phase. On the first follow-up CT scans, the mean attenuation values of the late arterial and portal venous phases were 76.9    26.5 HU and 94.2    29.1 HU, respectively (P < 0.01). The median OS was better for the @entity1 with the response of stable disease than the @entity1 with progressive disease (P = 0.013). CONCLUSIONS: In @entity1 with advanced @entity157 who were treated by @entity2857 , the size of the @entity99 was not significantly reduced. However, the median survival was better for the @entity1 with the response of stable disease. The attenuation values of the @entity5 became lower after treatment, as compared to the baseline CT scans.

Computed tomography findings of XXXX -treated @entity99 in @entity1 with @entity157 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity2857 :: ('MESH:C471405', 'Chemical') :: ['sorafenib'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'advanced hepatocellular carcinoma'] @entity99 :: ('MESH:D056486', 'Disease') :: ['hepatic tumors']
@entity2857 :: (MESH:C471405,Chemical) :: ['sorafenib']
